Loading...
Back to narrative

CHCT: Rising Quarterly Dividend Will Support Attractive Future Total Returns

Dividend Strength And FFO Resilience Will Support Outperformance Despite Headwinds

CHCT logo
CHCT
AnalystConsensusTarget
Not Invested
Published 15 May 2025

Update shared on 13 Dec 2025

Previous
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
-15.6%
7D
1.9%

Analysts have modestly reiterated their view on Community Healthcare Trust, keeping the price target effectively unchanged at approximately $17.80 per share, as slightly lower discount rate assumptions offset stable growth and margin expectations.

What's in the News

  • The Board of Directors approved an increase in the common stock cash dividend for the quarter ended September 30, 2025 to 0.475 dollars per share, payable November 21, 2025 to shareholders of record on November 7, 2025 (Key Developments)
  • The new quarterly dividend rate represents an annualized dividend of 1.90 dollars per share, which may enhance the stock's income profile for investors (Key Developments)
  • Community Healthcare Trust has raised its dividend every quarter since its Initial Public Offering, highlighting a multiyear track record of consistent dividend growth (Key Developments)

Valuation Changes

  • Fair Value: Remains unchanged at approximately $17.80 per share, indicating no revision to the intrinsic value estimate.
  • Discount Rate: Has fallen slightly from about 9.10 percent to approximately 9.05 percent, reflecting a marginally lower required return.
  • Revenue Growth: Is effectively unchanged at roughly 9.30 percent, suggesting stable expectations for top line expansion.
  • Net Profit Margin: Is essentially flat at about 13.15 percent, indicating no material change in projected profitability.
  • Future P/E: Has edged down slightly from around 30.39x to about 30.35x, implying a marginally lower valuation multiple on forward earnings.

Have other thoughts on Community Healthcare Trust?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.